2018
DOI: 10.1089/nat.2018.0738
|View full text |Cite
|
Sign up to set email alerts
|

Application of 2′-O-(2-N-Methylcarbamoylethyl) Nucleotides in RNase H-Dependent Antisense Oligonucleotides

Abstract: An RNase H-dependent antisense oligonucleotide (ASO), having the 2′-O-(2-N-methylcarbamoylethyl) (MCE) modification, was evaluated in vitro and in vivo. The antisense activities of an ASO having the MCE modification were comparable with those of an ASO having the 2′-O-methoxyethyl (MOE) modification in both in vitro and in vivo experiments. In contrast, the hepatotoxic potential of the ASO having the MCE modification was lower than that of the ASO having the MOE modification. Thus, these findings suggested tha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 16 publications
0
7
0
Order By: Relevance
“…300,301 Volanesorsen, approved for treatment with familial chylomicronemia syndrome, is also modified with 2 0 -MOE and PS, with a human plasma t 1/2 over 2 weeks after single SC administration. [302][303][304] Third generation ASOs contain different modifications, such as PMOs, PNAs and LNAs. One example are SSOs that bind specific RNA-target sequences and modulate pre-mRNA splicing by sterically blocking the binding of splicing factors to the pre-mRNA.…”
Section: Viral Delivery Of Large Double Stranded Dna Fragmentsmentioning
confidence: 99%
See 2 more Smart Citations
“…300,301 Volanesorsen, approved for treatment with familial chylomicronemia syndrome, is also modified with 2 0 -MOE and PS, with a human plasma t 1/2 over 2 weeks after single SC administration. [302][303][304] Third generation ASOs contain different modifications, such as PMOs, PNAs and LNAs. One example are SSOs that bind specific RNA-target sequences and modulate pre-mRNA splicing by sterically blocking the binding of splicing factors to the pre-mRNA.…”
Section: Viral Delivery Of Large Double Stranded Dna Fragmentsmentioning
confidence: 99%
“…Both preventing off-target effects and gathering more insights into mechanism of toxicity will remain of importance for developing chemically modified ASOs. 304,[313][314][315][316] 4.2.2 siRNA therapeutics. Over 20 years after RNAi discovery, siRNA therapeutics finally found their way into the clinic for gene silencing in biomedical research and disease treatment.…”
Section: Viral Delivery Of Large Double Stranded Dna Fragmentsmentioning
confidence: 99%
See 1 more Smart Citation
“…the stability as well as biological activity of ASOs are of utmost need. Sugar modification and phosphorothioate linkages have displayed notable improvement in the stability of DNAs but loss of biological function and cytotoxicity have also been observed (Masaki et al, 2018;Miroshnichenko et al, 2019;Shen et al, 2018Shen et al, , 2019, whereas 4ʹmodifications have been reported to considerably increase the resistance against nucleases and exhibit the RNase Hdependent degradation of mRNA (Kanazaki et al, 2000;Kano, Katsuragi, Maeda, & Ueno, 2018;Koizumi et al, 2018;Morita et al, 2003). Based on this information, we have synthesized a novel nucleoside analog 4 -MAE-T and compared its properties to known 4ʹ-AE-T. Also, we designed a new facile synthetic route for synthesizing corresponding nucleoside phosphoramidites with high total yield.…”
Section: Chandela Et Almentioning
confidence: 99%
“…ASOs affect protein levels via several mechanisms. Among them, RNAse H triggering represents the most relevant knockdown system, and via Watson-Crick hybridization, ASOs can form RNA-DNA hybrids that become RNAse H substrates [63,64]. Furthermore, they can modulate pre-mRNA splicing, reducing or restoring protein expression [65].…”
Section: Aptamers As Carriers For Asosmentioning
confidence: 99%